Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 421 AL 435

PUBMED

Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease.

Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA.

Mol Neurobiol. 2012 Feb;45(1):87-98. doi: 10.1007/s12035-011-8219-8. Review.

0

0

0

PUBMED

What is the outcome of rheumatic carditis in children with Sydenham's chorea?

Ekici F, Cetin II, Cevik BS, Senkon OG, Alpan N, Değerliyurt A, Güven A, Ateş C, Cakar N.

Turk J Pediatr. 2012 Mar-Apr;54(2):159-67.

0

0

0

PUBMED

Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study.

Hobbs NZ, Cole JH, Farmer RE, Rees EM, Crawford HE, Malone IB, Roos RA, Sprengelmeyer R, Durr A, Landwehrmeyer B, Scahill RI, Tabrizi SJ, Frost C.

Neuroimage Clin. 2012 Dec 9;2:204-11. doi: 10.1016/j.nicl.2012.12.001.

0

0

0

PUBMED

Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis.

Tofaris GK, Irani SR, Cheeran BJ, Baker IW, Cader ZM, Vincent A.

Neurology. 2012 Jul 10;79(2):195-6. doi: 10.1212/WNL.0b013e31825f0522. No abstract available.

0

0

0

PUBMED

The chorea of McLeod syndrome: progression to hypokinesia.

Miranda M, Jung HH, Danek A, Walker RH.

Mov Disord. 2012 Nov;27(13):1701-2. doi: 10.1002/mds.25224. No abstract available.

0

0

0

PUBMED

Huntington's disease: fighting on many fronts.

Andre R, Wild EJ, Tabrizi SJ.

Brain. 2012 Apr;135(Pt 4):998-1001. doi: 10.1093/brain/aws060. No abstract available.

0

0

0

PUBMED

Pluripotent stem cells models for Huntington's disease: prospects and challenges.

Carter RL, Chan AW.

J Genet Genomics. 2012 Jun 20;39(6):253-9. doi: 10.1016/j.jgg.2012.04.006. Review.

0

0

0

PUBMED

A genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's disease.

Miller JP, Yates BE, Al-Ramahi I, Berman AE, Sanhueza M, Kim E, de Haro M, DeGiacomo F, Torcassi C, Holcomb J, Gafni J, Mooney SD, Botas J, Ellerby LM, Hughes RE.

PLoS Genet. 2012;8(11):e1003042. doi: 10.1371/journal.pgen.1003042.

0

0

0

PUBMED

Deep brain stimulation in Huntington's disease: A 4-year follow-up case report.

Spielberger S, Hotter A, Wolf E, Eisner W, Müller J, Poewe W, Seppi K.

Mov Disord. 2012 May;27(6):806-7; author reply 807-8. doi: 10.1002/mds.24959. No abstract available.

0

0

0

PUBMED

Mutation in the CHAC gene in a family of autosomal dominant chorea-acanthocytosis.

Walker RH, Velayos-Baeza A, Bader B, Danek A, Saiki S.

Neurology. 2012 Jul 10;79(2):198-9; author reply 199. doi: 10.1212/01.wnl.0000416389.94466.01. No abstract available.

0

0

0

PUBMED

SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.

Wityak J, Prime ME, Brookfield FA, Courtney SM, Erfan S, Johnsen S, Johnson PD, Li M, Marston RW, Reed L, Vaidya D, Schaertl S, Pedret-Dunn A, Beconi M, Macdonald D, Muñoz-Sanjuan I, Dominguez C.

ACS Med Chem Lett. 2012 Oct 4;3(12):1024-8. doi: 10.1021/ml300241m.

0

0

0

PUBMED

Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.

Reetz K, Romanzetti S, Dogan I, Saß C, Werner CJ, Schiefer J, Schulz JB, Shah NJ.

Neuroimage. 2012 Oct 15;63(1):517-24. doi: 10.1016/j.neuroimage.2012.07.009.

0

0

0

PUBMED

α-Synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology.

Corrochano S, Renna M, Tomas-Zapico C, Brown SD, Lucas JJ, Rubinsztein DC, Acevedo-Arozena A.

Autophagy. 2012 Mar;8(3):431-2. doi: 10.4161/auto.19259.

0

0

0

PUBMED

P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.

Fan J, Gladding CM, Wang L, Zhang LY, Kaufman AM, Milnerwood AJ, Raymond LA.

Neurobiol Dis. 2012 Mar;45(3):999-1009. doi: 10.1016/j.nbd.2011.12.019.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy